Trinity Biotech plc (TRIB) — Strategic Asset Allocation Index
Trinity Biotech plc (TRIB) has a Strategic Asset Allocation Index of 39.6% as of June 2022. Strategic assets (PP&E of $6.26 Million plus long-term investments of $-) total $6.26 Million, measured against net assets of $15.82 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See TRIB equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Trinity Biotech plc Strategic Asset Allocation Index (2000–2019)
This chart shows how Trinity Biotech plc's Strategic Asset Allocation Index has evolved across 20 annual periods from 2000 to 2019. As of June 2022, the index stands at 39.6%, representing strategic assets of $6.26 Million against net assets of $15.82 Million USD. For live market cap and overall valuation, see how much is Trinity Biotech plc worth.
Annual Strategic Asset Allocation Index for Trinity Biotech plc (2000–2019)
The table below presents the year-by-year Strategic Asset Allocation Index for Trinity Biotech plc from 2000 to 2019, covering 20 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Trinity Biotech plc net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2019 | 197.1% | $9.29 Million | $9.29 Million | $- | $4.71 Million | ▲ +184.9 pp |
| 2018 | 12.2% | $5.36 Million | $5.36 Million | $- | $44.05 Million | ▲ +2.7 pp |
| 2017 | 9.4% | $6.16 Million | $5.80 Million | $360.00K | $65.20 Million | ▼ -2.9 pp |
| 2016 | 12.3% | $13.40 Million | $13.40 Million | $0.00 | $108.73 Million | ▲ +0.5 pp |
| 2015 | 11.9% | $25.35 Million | $20.66 Million | $4.69 Million | $213.89 Million | ▲ +0.4 pp |
| 2014 | 11.5% | $22.57 Million | $17.88 Million | $4.69 Million | $196.97 Million | ▲ +4.4 pp |
| 2013 | 7.1% | $12.99 Million | $12.99 Million | $- | $183.01 Million | ▲ +1.9 pp |
| 2012 | 5.2% | $8.88 Million | $8.88 Million | $- | $169.38 Million | ▲ +0.2 pp |
| 2011 | 5.0% | $7.63 Million | $7.63 Million | $- | $151.33 Million | ▲ +0.8 pp |
| 2010 | 4.2% | $6.00 Million | $6.00 Million | $- | $141.29 Million | ▼ -11.1 pp |
| 2009 | 15.3% | $12.17 Million | $12.17 Million | $- | $79.34 Million | ▼ -2.6 pp |
| 2008 | 18.0% | $11.86 Million | $11.86 Million | $- | $65.91 Million | ▼ -1.3 pp |
| 2007 | 19.3% | $26.41 Million | $26.41 Million | $- | $136.84 Million | ▲ +6.0 pp |
| 2006 | 13.3% | $22.25 Million | $22.25 Million | $- | $167.26 Million | ▼ -1.1 pp |
| 2005 | 14.4% | $19.20 Million | $19.20 Million | $- | $133.62 Million | ▲ +0.6 pp |
| 2004 | 13.7% | $15.94 Million | $15.94 Million | $- | $116.14 Million | ▼ -3.3 pp |
| 2003 | 17.0% | $13.66 Million | $13.66 Million | $- | $80.26 Million | ▲ +1.3 pp |
| 2002 | 15.7% | $9.88 Million | $9.88 Million | $- | $62.91 Million | ▲ +5.1 pp |
| 2001 | 10.6% | $5.97 Million | $5.97 Million | $- | $56.53 Million | ▲ +0.6 pp |
| 2000 | 9.9% | $5.47 Million | $5.47 Million | $- | $55.04 Million | — |